research
focus
modif
function
group
oseltamivir
neuraminidas
inhibitor
influenza
viru
subtyp
interact
three
best
ligand
evalu
hydrat
state
use
molecular
dynam
simul
two
differ
temperatur
dock
result
show
ligand
n
hydroxymethyl
oxi
better
bind
energi
valu
standard
oseltamivir
sever
interact
includ
hydrogen
bond
residu
catalyt
site
neuraminidas
identifi
molecular
dynam
simul
result
show
ligand
use
good
candid
neuraminidas
inhibitor
cope
influenza
viru
subtyp
neuraminidas
becom
main
target
drug
design
influenza
viru
due
highli
conserv
catalyt
site
essenti
role
influenza
viru
replic
oseltamivir
antivir
drug
neuraminidas
use
prevent
viral
replic
last
stage
viral
live
cycl
directli
interact
catalyt
residu
neuraminidas
catalyt
site
framework
residu
stabil
enzym
structur
resist
oseltamivir
alreadi
becom
widespread
phenomenon
predict
neuraminidas
structur
show
resist
could
sever
time
higher
resist
zanamivir
neuraminidas
inhibitor
mutat
conserv
residu
neuraminidas
appear
associ
oseltamivir
resist
subtyp
specif
manner
three
known
type
mutat
manifest
oseltamivir
resist
influenza
viru
frequenc
mutant
virus
although
vari
among
differ
countri
high
preval
mutant
viru
seen
south
africa
new
caledonia
new
zealand
philippin
australia
modest
singapor
malaysia
thailand
insignific
macau
taiwan
search
effect
drug
cope
still
ongo
li
et
al
search
zinc
fragment
databas
found
lead
compound
feasibl
drug
candid
drug
resist
tendeci
oseltamivir
toward
provid
valuabl
data
drug
design
six
analog
inhibitor
drug
candid
suggest
du
et
al
robust
bind
energi
zanamivir
oseltamivir
found
compound
deriv
oseltamivir
good
bioavaibl
effect
treatment
prevent
epidem
influenza
infect
adult
adolesc
children
one
year
age
modifc
oseltamivir
cope
influenza
viru
subtyp
attempt
base
properti
amino
acid
residu
catalyt
site
neuraminidas
drugtarget
interact
investig
use
structur
bioinformat
tool
studi
focus
modif
oseltamivir
function
group
molecular
dock
perform
determin
best
candid
ligand
base
lowest
bind
energi
interact
molecular
dynam
simul
use
theoret
tool
analyz
proteinligand
interact
atom
resolut
base
classic
mechan
also
carri
molecular
dynam
simul
evalu
interact
candid
ligand
enzym
hydrat
state
two
differ
temperatur
sequenc
align
homolog
model
neuraminidas
neuraminidas
sequenc
mutat
download
nation
center
biotechnolog
inform
ncbi
influenza
viru
sequenc
databas
http
wwwncbimlmnihgovgenomesflu
multipl
sequenc
align
method
base
clustal
program
wwwebiacuktool
align
result
forward
homolog
pipelin
process
structur
determin
homolog
model
perform
use
swiss
model
access
http
wwwswissmodelexpasi
orgswissmodelhtml
chain
protein
data
bank
pdb
code
mutat
templat
appli
build
latest
structur
valid
structur
homolog
model
perform
protein
geometri
program
superimpos
superpos
program
moe
softwar
base
superimposit
rootmeansquar
deviat
rmsd
calcul
identifi
structur
similar
templat
model
mutat
structur
homolog
model
modif
oseltamivir
function
group
conduct
alcohol
aldehyd
keton
carboxyl
acid
esther
amid
oglycosid
apiosid
group
use
acd
lab
softwar
modifi
oseltamivir
built
structur
use
acd
lab
softwar
shape
obtain
save
viewer
acd
lab
furthermor
output
format
convert
molfil
mdl
mol
format
use
softwar
vegazz
conform
dock
process
ligand
wash
comput
program
adjust
made
ligand
partial
charg
partial
charg
optim
use
forcefield
conform
structur
energi
ligand
minim
use
rootmeansquar
rm
gradient
energi
kcalmol
paramet
accord
exist
default
moe
softwar
molecular
dock
moe
appli
optim
minim
structur
enzym
addit
hydrogen
atom
proton
employ
proton
program
introduc
chang
ioniz
step
wash
process
start
optim
pipelin
moe
databas
viewer
furthermor
partial
charg
forc
field
modif
appli
solvat
enzym
perform
form
ga
phase
fix
charg
rm
gradient
kcal
mol
paramet
use
standard
moe
softwar
initi
dock
process
appli
moe
dock
simul
perform
computesimul
dock
program
dock
procedur
ligand
flexibl
wherea
receptor
fix
applic
triangl
matcher
placement
method
iter
total
energi
read
per
posit
paramet
tune
perform
standard
default
valu
moe
total
popul
score
function
util
londondg
repetit
forc
field
first
repetit
second
set
shown
one
best
result
score
use
london
dg
estim
gibb
bind
energi
dg
bind
pose
ligand
enzym
base
calcul
c
rotat
entropi
rate
translat
obtain
releas
e
flex
flexibl
ligand
energi
f
hb
imperfect
size
geometri
hydrogen
bond
c
hb
energi
ideal
hydrogen
bond
f
imperfect
size
geometri
metal
ligat
c
ideal
metal
ligat
energi
atom
desolv
energi
analysi
ligand
interact
enzym
temperatur
k
k
employ
ligx
tool
moe
softwar
molecular
dynam
simul
carri
differ
temperatur
use
simulationsdynam
program
moe
softwar
solvat
potenti
setup
born
rm
gradient
geometri
optim
energi
minim
structur
neuraminidas
complex
ligand
perfom
moe
softwar
geometri
optim
use
partial
charg
current
forc
field
energi
minim
employ
ensembl
paramet
perform
nvt
n
number
atom
v
volum
temperatur
npa
algorithm
cutoff
restraint
dynam
simul
stage
involv
initi
ps
main
simul
equilibrium
product
stage
produc
trajectori
molecular
dynam
simul
complex
enzymeligand
temperatur
k
employ
main
simul
ps
cool
ps
molecular
dynam
simul
temperatur
k
employ
heat
temperatur
k
k
ps
main
simul
employ
ps
cool
ps
posit
veloc
acceler
save
everi
ps
paramet
perform
accord
default
moe
dynam
paramet
born
solvat
caus
solvat
energi
e
sol
calcul
potenti
energi
molecular
system
function
atom
coordin
e
str
stretch
energi
e
ang
angular
energi
e
stb
stretch
bend
energi
e
oop
oper
energi
e
tor
energi
torsion
e
vdw
intermolecul
van
der
waal
energi
e
ele
electrostat
energi
e
sol
solvat
energi
dan
e
re
residu
move
energi
see
clearli
esol
equat
interact
ligand
residu
simul
analyz
use
ligx
ligand
interact
moe
softwar
visual
differ
conform
occur
simul
analyz
use
surfac
map
program
moe
softwar
neuraminidas
sequenc
neuraminidas
influenza
viru
use
target
sequenc
similar
templat
chain
pdb
code
accordingli
align
result
employ
build
homolog
model
superimpos
templat
homolog
model
neuraminidas
influenza
viru
obtain
use
templat
chain
contain
mutat
identifi
oseltamivirresist
strain
reliabl
homolog
model
identifi
ramachandran
plot
limit
orang
area
coordin
secondari
protein
structur
maximum
toler
limit
area
steric
strain
fig
area
allow
region
protein
blue
line
put
amino
acid
outlier
dissallow
region
toler
limit
area
residu
plot
glysin
allow
side
chain
make
q
phi
psi
angl
limit
number
residu
plot
besid
glysin
show
qualiti
protein
structur
result
ramachandran
plot
show
outlier
residu
core
region
ramachandran
map
homolog
model
use
dock
process
superimposit
use
find
degre
similar
templat
chain
pdb
code
homolog
model
rmsd
calcul
find
structur
similar
protein
rmsd
valu
superimposit
indic
homolog
model
close
structur
similar
therefor
use
dock
process
total
oseltamivir
modifi
ligand
oseltamivir
screen
use
molecular
dock
base
lowest
bind
energi
dg
dock
ligand
result
best
ligand
repeat
dock
result
best
ligand
screen
base
lipinski
rule
five
show
molecular
weight
drug
like
must
gmol
screen
best
ligand
result
ligand
ligand
screen
result
three
best
ligand
select
base
quantiti
hydrogen
catalyt
site
neuraminidas
three
best
ligand
oglycosid
apiosid
group
function
group
modifi
oseltamivir
ligand
apiosid
group
greatli
enhanc
inhibitori
activ
similar
oglicosid
compound
inhibitori
activ
neuraminidas
especi
hydrol
influenza
viru
sialidas
tabl
properti
three
best
ligand
oseltamivir
standard
ligand
show
ligand
lowest
bind
energi
oseltamivir
standard
level
lowest
dg
valu
ligand
dg
kcalmol
respect
valu
better
oseltamivir
standard
ligand
dg
kcalmol
pki
valu
ligand
mm
respect
valu
better
pki
valu
oseltamivir
mm
pki
valu
ligand
indic
ligand
effect
better
affin
strongli
interact
neuraminidas
oseltamivir
molecular
weight
ligand
gmol
ligand
number
bind
catalyt
site
bind
respect
tabl
ligand
bind
catalyt
site
chosen
molecular
dynam
simul
oseltamvir
fewer
bind
catalyt
site
hydrogen
bond
amino
acid
residu
neuraminidas
ligand
oseltamivir
shown
tabl
ligand
bind
affin
catalyt
site
oseltamivir
ligand
hydrogen
bond
two
bind
arg
two
bind
four
bind
ligand
hydrogen
bond
three
bind
two
bind
three
bind
ligand
hydrogen
bond
neuraminidas
ligand
mani
hydrogen
bond
interact
catalyt
site
neuraminidas
dock
pose
three
ligand
shown
fig
hydrogen
bond
chosen
basi
molecular
dynam
simul
evolut
time
hydrogen
bond
inhibitorenzym
complex
provid
approach
evalu
converg
dynam
properti
system
interact
best
ligand
enzym
evalu
hydrat
state
use
molecular
dynam
simul
two
differ
temperatur
k
k
simul
temperatur
k
chosen
evalu
interact
complex
enzymeligand
room
temperatur
simul
temperatur
k
chosen
evalu
interact
complex
enzymeligand
fever
shown
tabl
good
interact
ligand
compar
oseltamivir
standard
ligand
fig
better
interact
two
simul
temperatur
k
k
interact
form
hydrogen
bond
much
stabl
molecular
dock
end
simul
howev
interact
molecular
dock
molecular
dynam
simul
decreas
hydrogen
bond
hydrogen
bond
end
simul
temperatur
k
k
respect
stabil
hydrogen
bond
occur
one
catalyt
residu
neuraminidas
nh
function
group
ligand
simul
temperatur
k
fig
stabil
hydrogen
bond
also
occur
function
group
simul
k
stabil
hydrogen
bond
also
increas
simul
k
alcohol
apiosid
group
function
group
ligand
interact
catalyt
residu
neuraminidas
result
two
hydrogen
bond
fig
compar
interact
hydrogen
bond
dock
bind
catalyt
site
interact
simul
could
form
hydrogen
bond
due
mobil
amino
acid
residu
catalyt
site
differ
motion
solvent
hydrat
condit
motion
prove
dynam
enzym
due
effect
solvent
molecul
presenc
differ
function
group
ligand
variou
bond
effect
result
differ
conform
stabl
interact
ligand
form
hydrogen
bond
simul
two
differ
temperatur
provid
solid
evid
ligand
affin
neuraminidas
complet
ligand
interact
data
supplementari
materi
http
wwwbioinfunileipzigd
arlisupplementarymaterialpdf
shown
fig
chang
conform
ligand
complex
occur
simul
show
dynam
behaviour
enzym
presenc
solvent
ligand
ligand
remain
bind
pocket
dock
initi
stage
end
simul
k
k
bind
pocket
complex
chang
close
form
open
state
end
simul
base
simul
result
chang
conform
ligand
complex
simul
caus
apiosid
ammonium
function
group
form
stabl
interact
compar
other
function
group
name
pentyloxi
aldehyd
carboxyl
form
hydrogen
bond
bind
pocket
conform
figur
ligand
list
supplementari
materi
fig
f
show
ligandreceptor
interact
inde
reach
stabil
ps
would
suggest
ligand
drug
candid
within
stabl
condit
human
bodi
fig
rmsd
graphic
neuraminidas
na
dynam
k
x
axi
repres
molecular
dynam
time
durat
picosecond
ps
axi
repres
rmsd
valu
graphic
show
ps
structur
becom
stabl
b
rmsd
graphic
neuraminidas
na
dynam
k
graphic
show
ps
structur
becom
stabl
c
rmsd
graphic
neuraminidas
na
dynam
k
graphic
show
ps
structur
becom
stabl
rmsd
graphic
neuraminidas
na
dynam
k
graphic
show
ps
structur
becom
stabl
e
rmsd
graphic
neuraminidas
na
dynam
k
graphic
show
ps
structur
becom
stabl
f
rmsd
graphic
neuraminidas
na
dynam
k
graphic
show
ps
structur
becom
stabl
research
contribut
function
group
ligand
n
hydroxymethyl
oxi
apiosid
ammonium
group
provid
better
interact
form
hydrogen
bond
affin
neuraminidas
oseltamivir
due
polar
function
group
function
group
abl
form
interact
neuraminidas
polar
hydrophil
residu
catalyt
site
apiosid
group
form
two
hydrogen
bond
ammonium
group
form
one
hydrogen
bond
residu
catalyt
site
neuraminidas
result
interact
apiosid
ammonium
group
residu
catalyt
site
neuraminidas
indic
ligand
inhibit
neuraminidas
ligand
propos
candid
neuraminidas
inhibitor
influenza
viru
subtyp
outlook
studi
awar
research
group
alreadi
produc
rna
base
drug
interf
influenza
viru
moreov
feasibl
power
transcriptom
base
tool
gener
viral
bioinformat
research
end
would
interest
investig
transcriptom
properti
viru
supplementari
approach
exist
proteom
method
conclus
built
latest
structur
model
homolog
model
excel
reliabl
use
ramachandran
plot
templat
superimposit
total
oseltamivir
modifi
ligand
molecul
design
screen
molecular
dock
three
best
ligand
obtain
lowest
bind
energi
contradict
otv
standard
ligand
interact
evalu
hydrat
state
use
molecular
dynam
simul
work
provid
ligand
stabl
interact
glu
arg
simul
temperatur
k
k
respect
base
result
ligand
use
candid
neuraminidas
inhibitor
influenza
viru
subtyp
